The Multifaceted Role of Nurses in Addressing the Opioid Crisis: Comprehensive Strategies for Prevention, Intervention, and Care
DOI:
https://doi.org/10.22399/ijcesen.4792Keywords:
Nursing, Opioid Crisis, Opioid Use Disorder (OUD), Medication-Assisted Treatment (MAT), Harm Reduction, NaloxoneAbstract
The opioid crisis, a multifaceted public health emergency, demands a comprehensive response where nurses play an indispensable and transformative role. As the largest and most trusted segment of the healthcare workforce, nurses operate at the critical intersection of clinical care, prevention, education, and advocacy. On the frontline, they provide lifesaving interventions such as naloxone administration and manage withdrawal, while also delivering the gold-standard treatment of Medication-Assisted Treatment (MAT) within an integrated, trauma-informed framework. Their sustained patient relationships form the foundation for effective screening, brief intervention, and harm reduction strategies. Beyond direct care, nurses are pivotal in primary prevention through patient education on opioid risks and promotion of non-opioid pain management, and they serve as powerful advocates in combating stigma and shaping equitable health policy. To fully leverage this potential, investment in specialized nursing education and research is essential. Ultimately, empowering the nursing profession is not merely beneficial but a fundamental necessity for developing sustainable, compassionate, and effective solutions to the opioid epidemic.
References
1. Ellenbecker, C. H. , Fawcett J., Jones E. J., Mahoney D., Rowlands B., and Waddell A.. 2017. “A Staged Approach to Educating Nurses in Health Policy.” Policy, Politics & Nursing Practice 18, no. 1: 44–56. 10.1177/1527154417709254.
2. Kyei, E. F. , Zhang L., and Leveille S.. 2024. “A Conceptual Analysis of Opioid Use Disorder in Chronic Noncancer Pain Using Rodger's Evolutionary Approach.” Pain Management Nursing 25: 354–362. 10.1016/j.pmn.2024.03.017.
3. Dowell, D. , Ragan K. R., Jones C. M., Baldwin G. T., and Chou R.. 2022. “CDC Clinical Practice Guideline for Prescribing Opioids for Pain—United States, 2022.” MMWR. Recommendations and Reports: Morbidity and Mortality Weekly Report. Recommendations and Reports 71, no. 3: 1–95. 10.15585/mmwr.rr7103a1.
4. Haffajee, R. L. , Lin L. A., Bohnert A. S. B., and Goldstick J. E.. 2019. “Characteristics of US Counties With High Opioid Overdose Mortality and Low Capacity to Deliver Medications for Opioid Use Disorder.” JAMA Network Open 2, no. 6: e196373. 10.1001/jamanetworkopen.2019.6373.
5. Judd, H. , Meier C. L., Yaugher A. C., Campbell E., and Atismé‐Bevins K.. 2023. “Opioid Use Disorder Stigma Reduction Through Story Telling Narrative and Sharing: A Qualitative Review and Lessons Learned.” International Journal of Mental Health and Addiction 21, no. 1: 468–483. 10.1007/s11469-021-00606-y.
6. Azagba, S. , Shan L., Manzione L., Qeadan F., and Wolfson M.. 2019. “Trends in Opioid Misuse Among Marijuana Users and Non‐Users in the U.S. From 2007–2017.” International Journal of Environmental Research and Public Health 16, no. 22. 10.3390/ijerph16224585.
7. Kleinman, M. B. , Felton J. W., Johnson A., and Magidson J. F.. 2021. ““I Have to Be Around People That Are Doing What I'm Doing”: The Importance of Expanding the Peer Recovery Coach Role in Treatment of Opioid Use Disorder in the Face of COVID‐19 Health Disparities.” Journal of Substance Abuse Treatment 122: 108182. 10.1016/j.jsat.2020.108182.
8. Alpert, A. , Evans W. N., Lieber E. M. J., and Powell D.. 2021. “Origins of the Opioid Crisis and its Enduring Impacts.” The Quarterly Journal of Economics 137, no. 2: 1139–1179. 10.1093/qje/qjab043.
9. Csete, J. 2019. “Criminal Justice Barriers to Treatment of Opioid Use Disorders in the United States: The Need for Public Health Advocacy.” American Journal of Public Health 109, no. 3: 419–422. 10.2105/AJPH.2018.304852.
10. Hutchison, M. , Russell B. S., Leander A., et al. 2023. “Trends and Barriers of Medication Treatment for Opioid Use Disorders: A Systematic Review and Meta‐Analysis.” Journal of Drug Issues. 10.1177/00220426231204841.
11. Coady, J. A. , and Nadal N. C.. 2023. “Strengthening Prevention Systems to Address the Overdose Crisis Through the HEAL Prevention Cooperative and HEAL Preventing Opioid Use Disorder Research Program.” Prevention Science 24, no. 1: 119–128. 10.1007/s11121-023-01579-1.
12. Gormley, M. A. , Pericot‐Valverde I., Diaz L., et al. 2021. “Effectiveness of Peer Recovery Support Services on Stages of the Opioid Use Disorder Treatment Cascade: A Systematic Review.” Drug and Alcohol Dependence 229: 109123. 10.1016/j.drugalcdep.2021.109123.
13. Kyei, E. F. , and Leveille S.. 2023. “Opioid Misuse and Opioid Overdose Mortality Among the Black Population in the United States: An Integrative Review.” Policy, Politics & Nursing Practice 24, no. 3: 208–218. 10.1177/15271544231164323.
14. Elswick, A. , Werner‐Wilson R., and Fallin‐Bennett A.. 2021. “Voices of Hope: A Randomized Controlled Trial of a Peer‐Delivered Telephone Recovery Support Program.” Journal of Addiction Science 7, no. 1: 18–29. 10.17756/jas.2021-052.
15. Altekruse, S. F. , Cosgrove C. M., Altekruse W. C., Jenkins R. A., and Blanco C.. 2020. “Socioeconomic Risk Factors for Fatal Opioid Overdoses in the United States: Findings From the Mortality Disparities in American Communities Study (MDAC).” PLoS One 15, no. 1: e0227966.
16. Carroll, J. J. , Asher A., Krishnasamy V., and Dowell D.. 2022. Linking People With Opioid Use Disorder to Medication Treatment: A Technical Package of Policy, Programs, and Practices. Atlanta, Georgia: National Center for Injury Prevention and Control.
17. Marshall, B. D. L. , Green T. C., Elston B., Yedinak J. L., Hadland S. E., and Clark M. A.. 2018. “The Effectiveness of Internet‐ and Field‐Based Methods to Recruit Young Adults Who Use Prescription Opioids Nonmedically.” Substance Use & Misuse 53, no. 10: 1688–1699. 10.1080/10826084.2018.1425725.
18. Kacinko, S. L. , Mohr A. L. A., Logan B. K., and Barbieri E. J.. 2022. “Xylazine: Pharmacology Review and Prevalence and Drug Combinations in Forensic Toxicology Casework.” Journal of Analytical Toxicology 46, no. 8: 911–917. 10.1093/jat/bkac049.
19. Ciccarone, D. 2021. “The Rise of Illicit Fentanyls, Stimulants and the Fourth Wave of the Opioid Overdose Crisis.” Current Opinion in Psychiatry 34, no. 4: 344–350.
20. Mattson, C. L. , Tanz L. J., Quinn K., Kariisa M., Patel P., and Davis N. L.. 2021. “Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths—United States, 2013–2019.” Morbidity and Mortality Weekly Report 70, no. 6: 202–207.
21. Kyei, E. F. , Kyei G. K., Ansong R., Boakye C. K., and Asamoah E.. 2024. “Xylazine in the Unregulated Drug Market: An Integrative Review of Its Prevalence, Health Impacts, and Detection and Intervention Challenges in the United States. Policy, Politics, & Nursing.” Practice. 10.1177/15271544241268386.
22. Nielsen, S. , Scott N., Tidhar T., Quiroga M. d. M., Lenton S., and Dietze P.. 2022. “The Cost and Impact of Distributing Naloxone to People Who Are Prescribed Opioids to Prevent Opioid‐Related Deaths: Findings From a Modelling Study.” Addiction 117, no. 4: 1009–1019. 10.1111/add.15727.
23. Abram, M. D. 2018. “The Role of the Registered Nurse Working in Substance Use Disorder Treatment: A Hermeneutic Study.” Issues in Mental Health Nursing 39, no. 6: 490–498. 10.1080/01612840.2017.1413462.
24. Cheetham, A. , Picco L., Barnett A., Lubman D. I., and Nielsen S.. 2022. “The Impact of Stigma on People With Opioid Use Disorder, Opioid Treatment, and Policy.” Substance Abuse and Rehabilitation 13: 1–12. 10.2147/SAR.S304566.
25. Chandler, R. , Nunes E. V., Tan S., et al. 2023. “Community Selected Strategies to Reduce Opioid‐Related Overdose Deaths in the HEALing (Helping to End Addiction Long‐Term SM) Communities Study.” Drug and Alcohol Dependence 245: 109804. 10.1016/j.drugalcdep.2023.109804.
26. Marcovitz, D. E. , White K. D., Sullivan W., et al. 2021. “Bridging Recovery Initiative Despite Gaps in Entry (BRIDGE): Study Protocol for a Randomized Controlled Trial of a Bridge Clinic Compared With Usual Care for Patients With Opioid Use Disorder.” Trials 22, no. 1: 757. 10.1186/s13063-021-05698-4.
27. Joseph, G. , Torres‐Lockhart K., Stein M. R., Mund P. A., and Nahvi S.. 2021. “Reimagining Patient‐Centered Care in Opioid Treatment Programs: Lessons From the Bronx During COVID‐19.” Journal of Substance Abuse Treatment 122: 108219. 10.1016/j.jsat.2020.108219.
28. Centers for Disease Control and Prevention . 2023. “Provisional Drug Overdose Deaths Counts.” National Center for Health Statistics. www.cdc.gov/nchs/nvss/vsrr/drug‐overdose‐data.htm.
29. Edelman, L. S. , and Hemmert R.. 2019. “Opioid Use in Long‐Term Care: Guidelines and Policy Recommendations.” Journal of Gerontological Nursing 45, no. 9: 5–10. 10.3928/00989134-20190813-02.
30. Cano, M. , and Huang Y.. 2021. “Overdose Deaths Involving Psychostimulants With Abuse Potential, Excluding Cocaine: State‐Level Differences and the Role of Opioids.” Drug and Alcohol Dependence 218: 108384. 10.1016/j.drugalcdep.2020.108384.
31. Alexander, R. S. , Canver B. R., Sue K. L., and Morford K. L.. 2022. “Xylazine and Overdoses: Trends, Concerns, and Recommendations.” American Journal of Public Health 112, no. 8: 1212–1216. 10.2105/AJPH.2022.306881.
32. Nguemeni Tiako, M. J. 2021. “Addressing Racial & Socioeconomic Disparities in Access to Medications for Opioid Use Disorder Amid COVID‐19.” Journal of Substance Abuse Treatment 122: 108214. 10.1016/j.jsat.2020.108214.
33. Grella, C. E. , Ostile E., Scott C. K., Dennis M., and Carnavale J.. 2020. “A Scoping Review of Barriers and Facilitators to Implementation of Medications for Opioid Use Disorder Within the Criminal Justice System.” International Journal of Drug Policy 81: 102768. 10.1016/j.drugpo.2020.102768.
34. Drainoni, M.‐L. , Knudsen H. K., Adams K., et al. 2022. “Community Coalition and Key Stakeholder Perceptions of the Community Opioid Epidemic Before an Intensive Community‐Level Intervention.” Journal of Substance Abuse Treatment 138: 108731. 10.1016/j.jsat.2022.108731.
35. Madras, B. K. , Ahmad N. J., Wen J., and Sharfstein J.. 2020. “Improving Access to Evidence‐Based Medical Treatment for Opioid Use Disorder: Strategies to Address Key Barriers Within the Treatment System.” NAM Perspectives. 10.31478/202004b.
36. Hood, C. M. , Gennuso K. P., Swain G. R., and Catlin B. B.. 2016. “County Health Rankings.” American Journal of Preventive Medicine 50, no. 2: 129–135. 10.1016/j.amepre.2015.08.024.
37. Martin, T. , Maguire T., Quinn C., Ryan J., Bawden L., and Summers M.. 2013. “Standards of Practice for Forensic Mental Health Nurses—Identifying Contemporary Practice.” Journal of Forensic Nursing 9, no. 3: 171–178.
38. Chandler, R. K. , Villani J., Clarke T., McCance‐Katz E. F., and Volkow N. D.. 2020. “Addressing Opioid Overdose Deaths: The Vision for the HEALing Communities Study.” Drug and Alcohol Dependence 217: 108329. 10.1016/j.drugalcdep.2020.108329.
39. Manchak, S. M. , Gosney M. E., Haberman C., and Firesheets K. C.. 2022. “A Data‐Driven Response to the Addiction Crisis in Hamilton County, Ohio.” Journal of Public Health Management and Practice 28, no. Supplement 6: S320–S325.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 International Journal of Computational and Experimental Science and Engineering
This work is licensed under a Creative Commons Attribution 4.0 International License.
